

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 5.63314533 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.40887630 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.12823389 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.03944503 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.83925793 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.76263476 |
| 7 | response to pheromone (GO:0019236) | 4.70225053 |
| 8 | cell migration in hindbrain (GO:0021535) | 4.67458718 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 4.32901528 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.26968150 |
| 11 | glutamate secretion (GO:0014047) | 4.20051247 |
| 12 | postsynaptic membrane organization (GO:0001941) | 4.14626773 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.06963037 |
| 14 | behavioral response to nicotine (GO:0035095) | 4.05597925 |
| 15 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.87547979 |
| 16 | protein localization to synapse (GO:0035418) | 3.85011095 |
| 17 | neurotransmitter secretion (GO:0007269) | 3.84896666 |
| 18 | layer formation in cerebral cortex (GO:0021819) | 3.84237117 |
| 19 | striatum development (GO:0021756) | 3.80429689 |
| 20 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.76362826 |
| 21 | axon cargo transport (GO:0008088) | 3.75215459 |
| 22 | vocalization behavior (GO:0071625) | 3.73543837 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.70594958 |
| 24 | synaptic vesicle endocytosis (GO:0048488) | 3.70171440 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.67258040 |
| 26 | presynaptic membrane assembly (GO:0097105) | 3.66064443 |
| 27 | locomotory exploration behavior (GO:0035641) | 3.65300465 |
| 28 | dendritic spine morphogenesis (GO:0060997) | 3.65052155 |
| 29 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.60730334 |
| 30 | cellular potassium ion homeostasis (GO:0030007) | 3.60548183 |
| 31 | neuromuscular process controlling posture (GO:0050884) | 3.60510034 |
| 32 | membrane depolarization during action potential (GO:0086010) | 3.59286026 |
| 33 | presynaptic membrane organization (GO:0097090) | 3.55837966 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.54542409 |
| 35 | negative regulation of microtubule polymerization (GO:0031115) | 3.54518972 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.51300131 |
| 37 | mating behavior (GO:0007617) | 3.48256923 |
| 38 | innervation (GO:0060384) | 3.46761639 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 3.46668239 |
| 40 | sodium ion export (GO:0071436) | 3.43407466 |
| 41 | proline transport (GO:0015824) | 3.40490862 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.40164243 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.37774620 |
| 44 | auditory behavior (GO:0031223) | 3.35594883 |
| 45 | serotonin metabolic process (GO:0042428) | 3.35379731 |
| 46 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.33340243 |
| 47 | mitochondrion transport along microtubule (GO:0047497) | 3.33340243 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.30714128 |
| 49 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.27485644 |
| 50 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.26345981 |
| 51 | detection of temperature stimulus (GO:0016048) | 3.26135830 |
| 52 | neurotransmitter transport (GO:0006836) | 3.25980426 |
| 53 | prepulse inhibition (GO:0060134) | 3.25735716 |
| 54 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.25636200 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25165085 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.24535607 |
| 57 | transmission of nerve impulse (GO:0019226) | 3.24153245 |
| 58 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22733510 |
| 59 | regulation of synapse structural plasticity (GO:0051823) | 3.22127666 |
| 60 | neuron recognition (GO:0008038) | 3.20566135 |
| 61 | potassium ion homeostasis (GO:0055075) | 3.17898558 |
| 62 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.14334880 |
| 63 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.14334880 |
| 64 | exploration behavior (GO:0035640) | 3.12977945 |
| 65 | positive regulation of potassium ion transport (GO:0043268) | 3.12565052 |
| 66 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12090881 |
| 67 | neuromuscular synaptic transmission (GO:0007274) | 3.11215176 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.09940872 |
| 69 | adult walking behavior (GO:0007628) | 3.08336177 |
| 70 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.07917890 |
| 71 | organelle transport along microtubule (GO:0072384) | 3.06463982 |
| 72 | regulation of postsynaptic membrane potential (GO:0060078) | 3.06341554 |
| 73 | primary amino compound metabolic process (GO:1901160) | 3.06284487 |
| 74 | neuron-neuron synaptic transmission (GO:0007270) | 3.02867729 |
| 75 | membrane depolarization (GO:0051899) | 3.02458595 |
| 76 | synapse assembly (GO:0007416) | 2.97598490 |
| 77 | regulation of neurotransmitter levels (GO:0001505) | 2.96871667 |
| 78 | membrane hyperpolarization (GO:0060081) | 2.95092118 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 2.95059265 |
| 80 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.94715998 |
| 81 | neuronal action potential (GO:0019228) | 2.94635996 |
| 82 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.94123623 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.94030364 |
| 84 | neuronal ion channel clustering (GO:0045161) | 2.93680447 |
| 85 | cochlea development (GO:0090102) | 2.93021648 |
| 86 | positive regulation of dendritic spine development (GO:0060999) | 2.92199355 |
| 87 | startle response (GO:0001964) | 2.91836023 |
| 88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.91499817 |
| 89 | synaptic vesicle transport (GO:0048489) | 2.90787228 |
| 90 | establishment of synaptic vesicle localization (GO:0097480) | 2.90787228 |
| 91 | positive regulation of membrane potential (GO:0045838) | 2.90485316 |
| 92 | glycine transport (GO:0015816) | 2.90211171 |
| 93 | establishment of vesicle localization (GO:0051650) | 2.89767422 |
| 94 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.89486293 |
| 95 | neuromuscular process controlling balance (GO:0050885) | 2.88778648 |
| 96 | nucleobase catabolic process (GO:0046113) | 2.88512874 |
| 97 | regulation of vesicle fusion (GO:0031338) | 2.87966599 |
| 98 | dendrite morphogenesis (GO:0048813) | 2.87764391 |
| 99 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.87023145 |
| 100 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.87023145 |
| 101 | cerebellar granule cell differentiation (GO:0021707) | 2.86316011 |
| 102 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.85389006 |
| 103 | synaptic transmission (GO:0007268) | 2.84611452 |
| 104 | piRNA metabolic process (GO:0034587) | 2.84426033 |
| 105 | vesicle transport along microtubule (GO:0047496) | 2.84015672 |
| 106 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.83157434 |
| 107 | positive regulation of synapse maturation (GO:0090129) | 2.82616690 |
| 108 | regulation of synapse maturation (GO:0090128) | 2.82543359 |
| 109 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.82274900 |
| 110 | mechanosensory behavior (GO:0007638) | 2.82096647 |
| 111 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.81608044 |
| 112 | potassium ion export (GO:0071435) | 2.80544734 |
| 113 | axonal fasciculation (GO:0007413) | 2.79287476 |
| 114 | membrane repolarization (GO:0086009) | 2.79165882 |
| 115 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.79107515 |
| 116 | glutamate receptor signaling pathway (GO:0007215) | 2.78830833 |
| 117 | righting reflex (GO:0060013) | 2.77921012 |
| 118 | gamma-aminobutyric acid transport (GO:0015812) | 2.77311564 |
| 119 | behavioral defense response (GO:0002209) | 2.76582401 |
| 120 | behavioral fear response (GO:0001662) | 2.76582401 |
| 121 | L-amino acid import (GO:0043092) | 2.76368089 |
| 122 | cell communication involved in cardiac conduction (GO:0086065) | 2.75228036 |
| 123 | retinal cone cell development (GO:0046549) | 2.74966908 |
| 124 | activation of protein kinase A activity (GO:0034199) | 2.74046058 |
| 125 | action potential (GO:0001508) | 2.74001730 |
| 126 | regulation of membrane repolarization (GO:0060306) | 2.73649022 |
| 127 | regulation of neurotransmitter secretion (GO:0046928) | 2.73418141 |
| 128 | protein polyglutamylation (GO:0018095) | 2.72667418 |
| 129 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72456749 |
| 130 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.72391942 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 2.72073418 |
| 132 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.71804550 |
| 133 | neuromuscular process (GO:0050905) | 2.70109351 |
| 134 | microtubule-based transport (GO:0010970) | 2.69936006 |
| 135 | dopamine biosynthetic process (GO:0042416) | 2.69287643 |
| 136 | axon ensheathment in central nervous system (GO:0032291) | 2.65135190 |
| 137 | central nervous system myelination (GO:0022010) | 2.65135190 |
| 138 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.63294360 |
| 139 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.62989387 |
| 140 | response to auditory stimulus (GO:0010996) | 2.62007646 |
| 141 | C4-dicarboxylate transport (GO:0015740) | 2.61648057 |
| 142 | calcium ion-dependent exocytosis (GO:0017156) | 2.60453454 |
| 143 | regulation of dendritic spine development (GO:0060998) | 2.58861210 |
| 144 | positive regulation of synapse assembly (GO:0051965) | 2.58682376 |
| 145 | detection of calcium ion (GO:0005513) | 2.58531594 |
| 146 | adult behavior (GO:0030534) | 2.57980144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.59655575 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19777970 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.77520166 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69235791 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.67845513 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.57686688 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.41413149 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40237670 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40237670 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.30278083 |
| 11 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29620314 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26480491 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.24477830 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19893903 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.19624991 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11895318 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.10151182 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09073972 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.08960737 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01621339 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98221456 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97244352 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94538779 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93965114 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.92593359 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88983895 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86712023 |
| 28 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86114357 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85588901 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78534912 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78246216 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76892575 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73761860 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72974096 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71181394 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.65231262 |
| 37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62020191 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60651281 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58523044 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55318357 |
| 41 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.51364544 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50613011 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46330480 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44647838 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44498545 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44080678 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39884587 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36665131 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32314325 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32188163 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29328156 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28538836 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28257006 |
| 54 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.28229755 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27863869 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27844920 |
| 57 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.26801040 |
| 58 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.26003887 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24581357 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24442183 |
| 61 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24000338 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23802516 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.23461852 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21993668 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20155382 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19679835 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19482115 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18358107 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.17897016 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16716621 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16358588 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14785147 |
| 73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14118075 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12794179 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10334122 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10260618 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09995066 |
| 78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09940459 |
| 79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08791456 |
| 80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08270911 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06925674 |
| 82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06192218 |
| 83 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06009846 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05751852 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05200372 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05170004 |
| 87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04431259 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02971003 |
| 89 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02326334 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01683801 |
| 91 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00031502 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99141584 |
| 93 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99141584 |
| 94 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98639509 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98517177 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98249783 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96993398 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95861510 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95670988 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95643784 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94702482 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94476934 |
| 103 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94215056 |
| 104 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94026739 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93957991 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93753308 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93338974 |
| 108 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93266790 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93159542 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92668199 |
| 111 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.92545740 |
| 112 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91503512 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91040723 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90802496 |
| 115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90428730 |
| 116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90428730 |
| 117 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90250646 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89175897 |
| 119 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88983067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.21981285 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.17202823 |
| 3 | MP0004270_analgesia | 3.83390325 |
| 4 | MP0002735_abnormal_chemical_nociception | 3.34700635 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.24027673 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.12300885 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.10476623 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 3.07398025 |
| 9 | MP0002736_abnormal_nociception_after | 2.66199208 |
| 10 | MP0009046_muscle_twitch | 2.57888969 |
| 11 | MP0002733_abnormal_thermal_nociception | 2.51938399 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.47595972 |
| 13 | MP0002272_abnormal_nervous_system | 2.44644260 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.38820107 |
| 15 | MP0001970_abnormal_pain_threshold | 2.36554275 |
| 16 | MP0002064_seizures | 2.31387251 |
| 17 | MP0002184_abnormal_innervation | 2.28689347 |
| 18 | MP0009745_abnormal_behavioral_response | 2.22502490 |
| 19 | MP0001486_abnormal_startle_reflex | 2.20071911 |
| 20 | MP0001984_abnormal_olfaction | 2.17255006 |
| 21 | MP0004858_abnormal_nervous_system | 2.06322891 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.05824013 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.03266723 |
| 24 | MP0001529_abnormal_vocalization | 2.01309435 |
| 25 | MP0003329_amyloid_beta_deposits | 1.97025699 |
| 26 | MP0000778_abnormal_nervous_system | 1.96001794 |
| 27 | MP0000955_abnormal_spinal_cord | 1.87002643 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.76358314 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.73688860 |
| 30 | MP0003122_maternal_imprinting | 1.69827615 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.67567528 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.65435920 |
| 33 | MP0002882_abnormal_neuron_morphology | 1.61551153 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.55434694 |
| 35 | MP0003646_muscle_fatigue | 1.54938756 |
| 36 | MP0004924_abnormal_behavior | 1.54432881 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.54432881 |
| 38 | MP0003890_abnormal_embryonic-extraembry | 1.53015042 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.51538113 |
| 40 | MP0003787_abnormal_imprinting | 1.49971280 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.47575589 |
| 42 | MP0002229_neurodegeneration | 1.47140715 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.46764979 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.45711707 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.44631288 |
| 46 | MP0008569_lethality_at_weaning | 1.42998630 |
| 47 | MP0004142_abnormal_muscle_tone | 1.41086466 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.40274187 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.34584590 |
| 50 | MP0005394_taste/olfaction_phenotype | 1.33138951 |
| 51 | MP0005499_abnormal_olfactory_system | 1.33138951 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.33069675 |
| 53 | MP0002752_abnormal_somatic_nervous | 1.32316053 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.30233825 |
| 55 | MP0003121_genomic_imprinting | 1.26847052 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.21057886 |
| 57 | MP0001905_abnormal_dopamine_level | 1.18339618 |
| 58 | MP0002102_abnormal_ear_morphology | 1.12329581 |
| 59 | MP0008260_abnormal_autophagy | 1.09827033 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.08412912 |
| 61 | MP0003136_yellow_coat_color | 1.07482053 |
| 62 | MP0004742_abnormal_vestibular_system | 1.07367181 |
| 63 | MP0008789_abnormal_olfactory_epithelium | 1.06658260 |
| 64 | MP0002152_abnormal_brain_morphology | 1.06531564 |
| 65 | MP0003879_abnormal_hair_cell | 1.05348295 |
| 66 | MP0002822_catalepsy | 1.04372440 |
| 67 | MP0004043_abnormal_pH_regulation | 1.00391899 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.00121489 |
| 69 | MP0004885_abnormal_endolymph | 0.99756033 |
| 70 | MP0005253_abnormal_eye_physiology | 0.99070436 |
| 71 | MP0001299_abnormal_eye_distance/ | 0.99027975 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.98687648 |
| 73 | MP0004147_increased_porphyrin_level | 0.94416670 |
| 74 | MP0002751_abnormal_autonomic_nervous | 0.93965053 |
| 75 | MP0004133_heterotaxia | 0.93879632 |
| 76 | MP0004233_abnormal_muscle_weight | 0.93728536 |
| 77 | MP0002234_abnormal_pharynx_morphology | 0.93131761 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.92993718 |
| 79 | MP0003718_maternal_effect | 0.92460212 |
| 80 | MP0001963_abnormal_hearing_physiology | 0.90152789 |
| 81 | MP0006292_abnormal_olfactory_placode | 0.86696851 |
| 82 | MP0003631_nervous_system_phenotype | 0.86561675 |
| 83 | MP0008872_abnormal_physiological_respon | 0.86176515 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.85190084 |
| 85 | MP0000026_abnormal_inner_ear | 0.83273089 |
| 86 | MP0004036_abnormal_muscle_relaxation | 0.83065782 |
| 87 | MP0003861_abnormal_nervous_system | 0.82854046 |
| 88 | MP0003634_abnormal_glial_cell | 0.82162308 |
| 89 | MP0003119_abnormal_digestive_system | 0.82025453 |
| 90 | MP0000751_myopathy | 0.81995055 |
| 91 | MP0003632_abnormal_nervous_system | 0.81687361 |
| 92 | MP0003633_abnormal_nervous_system | 0.81403693 |
| 93 | MP0002160_abnormal_reproductive_system | 0.78858291 |
| 94 | MP0003123_paternal_imprinting | 0.77312296 |
| 95 | MP0004085_abnormal_heartbeat | 0.77272058 |
| 96 | MP0001177_atelectasis | 0.76858947 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.76379141 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.76072832 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.75452336 |
| 100 | MP0001188_hyperpigmentation | 0.73090569 |
| 101 | MP0002090_abnormal_vision | 0.72945746 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.72306454 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.71593932 |
| 104 | MP0000534_abnormal_ureter_morphology | 0.70764832 |
| 105 | MP0005187_abnormal_penis_morphology | 0.68987655 |
| 106 | MP0005195_abnormal_posterior_eye | 0.67993022 |
| 107 | MP0000462_abnormal_digestive_system | 0.66182217 |
| 108 | MP0000604_amyloidosis | 0.65998674 |
| 109 | MP0000569_abnormal_digit_pigmentation | 0.64060895 |
| 110 | MP0003011_delayed_dark_adaptation | 0.63644984 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.63216398 |
| 112 | MP0003698_abnormal_male_reproductive | 0.62829025 |
| 113 | MP0003195_calcinosis | 0.60883551 |
| 114 | MP0004130_abnormal_muscle_cell | 0.60153573 |
| 115 | MP0003938_abnormal_ear_development | 0.59675515 |
| 116 | MP0000566_synostosis | 0.59200103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.16107131 |
| 2 | Focal motor seizures (HP:0011153) | 4.56067071 |
| 3 | Ulnar claw (HP:0001178) | 4.52701506 |
| 4 | Focal seizures (HP:0007359) | 4.09189390 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.05144169 |
| 6 | Action tremor (HP:0002345) | 3.90566268 |
| 7 | Atonic seizures (HP:0010819) | 3.88854291 |
| 8 | Febrile seizures (HP:0002373) | 3.78862433 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.74304778 |
| 10 | Insidious onset (HP:0003587) | 3.57533964 |
| 11 | Termporal pattern (HP:0011008) | 3.57533964 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.45438181 |
| 13 | Central scotoma (HP:0000603) | 3.41323825 |
| 14 | Failure to thrive in infancy (HP:0001531) | 3.38659255 |
| 15 | Ankle clonus (HP:0011448) | 3.35182483 |
| 16 | Visual hallucinations (HP:0002367) | 3.30079652 |
| 17 | Hyperventilation (HP:0002883) | 3.24271689 |
| 18 | Type II lissencephaly (HP:0007260) | 3.23705946 |
| 19 | Abnormality of macular pigmentation (HP:0008002) | 3.16745567 |
| 20 | Pheochromocytoma (HP:0002666) | 3.15658687 |
| 21 | Absence seizures (HP:0002121) | 3.12548175 |
| 22 | Epileptic encephalopathy (HP:0200134) | 3.07089646 |
| 23 | Abnormal eating behavior (HP:0100738) | 3.05016949 |
| 24 | Spastic gait (HP:0002064) | 3.01647934 |
| 25 | Broad-based gait (HP:0002136) | 2.92745215 |
| 26 | Ventricular fibrillation (HP:0001663) | 2.92166962 |
| 27 | Mutism (HP:0002300) | 2.90372731 |
| 28 | Polyphagia (HP:0002591) | 2.89150631 |
| 29 | Abnormality of the corticospinal tract (HP:0002492) | 2.85965811 |
| 30 | Limb dystonia (HP:0002451) | 2.82338734 |
| 31 | Dialeptic seizures (HP:0011146) | 2.81399123 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.78297363 |
| 33 | Neuroendocrine neoplasm (HP:0100634) | 2.70199193 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69481731 |
| 35 | Gait imbalance (HP:0002141) | 2.59639825 |
| 36 | Lissencephaly (HP:0001339) | 2.58811584 |
| 37 | Status epilepticus (HP:0002133) | 2.58678310 |
| 38 | Fetal akinesia sequence (HP:0001989) | 2.50000644 |
| 39 | Hammertoe (HP:0001765) | 2.49183647 |
| 40 | Urinary urgency (HP:0000012) | 2.48952016 |
| 41 | Steppage gait (HP:0003376) | 2.48479480 |
| 42 | Hemiparesis (HP:0001269) | 2.48008156 |
| 43 | Inability to walk (HP:0002540) | 2.44156909 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.40453166 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.34769122 |
| 46 | Diplopia (HP:0000651) | 2.34769122 |
| 47 | Specific learning disability (HP:0001328) | 2.33932796 |
| 48 | Papillary thyroid carcinoma (HP:0002895) | 2.30289802 |
| 49 | Truncal ataxia (HP:0002078) | 2.28168922 |
| 50 | Abnormality of midbrain morphology (HP:0002418) | 2.27523310 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.27523310 |
| 52 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.27102099 |
| 53 | Hypoplasia of the brainstem (HP:0002365) | 2.26443962 |
| 54 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.26443962 |
| 55 | Insomnia (HP:0100785) | 2.24718833 |
| 56 | Severe visual impairment (HP:0001141) | 2.23663042 |
| 57 | Abnormality of the labia minora (HP:0012880) | 2.21449703 |
| 58 | Hypothermia (HP:0002045) | 2.21377014 |
| 59 | Depression (HP:0000716) | 2.18475820 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.16839555 |
| 61 | Dysmetria (HP:0001310) | 2.16054397 |
| 62 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.15705243 |
| 63 | Torticollis (HP:0000473) | 2.14869501 |
| 64 | Lower limb muscle weakness (HP:0007340) | 2.14803761 |
| 65 | Agitation (HP:0000713) | 2.14785447 |
| 66 | Genital tract atresia (HP:0001827) | 2.14322414 |
| 67 | Anosmia (HP:0000458) | 2.12616199 |
| 68 | Optic nerve hypoplasia (HP:0000609) | 2.11652651 |
| 69 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11509216 |
| 70 | Pancreatic cysts (HP:0001737) | 2.11065488 |
| 71 | Pachygyria (HP:0001302) | 2.10934672 |
| 72 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10688100 |
| 73 | Congenital primary aphakia (HP:0007707) | 2.10580815 |
| 74 | Abnormal hair whorl (HP:0010721) | 2.10225038 |
| 75 | Nephronophthisis (HP:0000090) | 2.09522219 |
| 76 | Scotoma (HP:0000575) | 2.09039521 |
| 77 | Protruding tongue (HP:0010808) | 2.07730343 |
| 78 | Cerebellar dysplasia (HP:0007033) | 2.04971127 |
| 79 | Vaginal atresia (HP:0000148) | 2.03683193 |
| 80 | Onion bulb formation (HP:0003383) | 2.03495786 |
| 81 | Progressive inability to walk (HP:0002505) | 2.02898549 |
| 82 | True hermaphroditism (HP:0010459) | 2.02145715 |
| 83 | Thyroid carcinoma (HP:0002890) | 2.00012687 |
| 84 | Amblyopia (HP:0000646) | 1.99843382 |
| 85 | Spastic tetraplegia (HP:0002510) | 1.98433757 |
| 86 | Esotropia (HP:0000565) | 1.97961692 |
| 87 | Abnormality of pain sensation (HP:0010832) | 1.97121241 |
| 88 | Impaired pain sensation (HP:0007328) | 1.97121241 |
| 89 | Peripheral hypomyelination (HP:0007182) | 1.96819068 |
| 90 | Poor eye contact (HP:0000817) | 1.96455910 |
| 91 | Dysdiadochokinesis (HP:0002075) | 1.96225607 |
| 92 | Impaired smooth pursuit (HP:0007772) | 1.95795350 |
| 93 | Decreased motor nerve conduction velocity (HP:0003431) | 1.95728253 |
| 94 | Retinal dysplasia (HP:0007973) | 1.95634565 |
| 95 | Bundle branch block (HP:0011710) | 1.94555913 |
| 96 | Excessive salivation (HP:0003781) | 1.94307655 |
| 97 | Drooling (HP:0002307) | 1.94307655 |
| 98 | Genetic anticipation (HP:0003743) | 1.94180516 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.93781412 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 1.93332763 |
| 101 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92866244 |
| 102 | Clonus (HP:0002169) | 1.92375654 |
| 103 | Postural instability (HP:0002172) | 1.91445822 |
| 104 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91347951 |
| 105 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90962370 |
| 106 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90962370 |
| 107 | Nephrogenic diabetes insipidus (HP:0009806) | 1.90809447 |
| 108 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88980466 |
| 109 | Gaze-evoked nystagmus (HP:0000640) | 1.88554184 |
| 110 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.87542859 |
| 111 | Epileptiform EEG discharges (HP:0011182) | 1.87249437 |
| 112 | Dyskinesia (HP:0100660) | 1.86422026 |
| 113 | Abnormality of the vocal cords (HP:0008777) | 1.85512066 |
| 114 | Abnormality of the fovea (HP:0000493) | 1.84692861 |
| 115 | Oligodactyly (hands) (HP:0001180) | 1.84551981 |
| 116 | Medial flaring of the eyebrow (HP:0010747) | 1.84383260 |
| 117 | Paraplegia (HP:0010550) | 1.83999825 |
| 118 | Poor coordination (HP:0002370) | 1.83424092 |
| 119 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.82779351 |
| 120 | Hypoplasia of the fovea (HP:0007750) | 1.82779351 |
| 121 | Hypoventilation (HP:0002791) | 1.81789727 |
| 122 | Absent speech (HP:0001344) | 1.81378201 |
| 123 | Anxiety (HP:0000739) | 1.81120351 |
| 124 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80575877 |
| 125 | Scanning speech (HP:0002168) | 1.79874196 |
| 126 | Syncope (HP:0001279) | 1.79443932 |
| 127 | Impaired social interactions (HP:0000735) | 1.79013111 |
| 128 | Abnormal social behavior (HP:0012433) | 1.79013111 |
| 129 | Abnormality of the foot musculature (HP:0001436) | 1.78148776 |
| 130 | Hypsarrhythmia (HP:0002521) | 1.77546802 |
| 131 | Distal sensory impairment (HP:0002936) | 1.77045663 |
| 132 | Focal dystonia (HP:0004373) | 1.76492953 |
| 133 | Abnormality of the renal cortex (HP:0011035) | 1.75427153 |
| 134 | Abnormality of the renal medulla (HP:0100957) | 1.74483724 |
| 135 | Sleep apnea (HP:0010535) | 1.74253488 |
| 136 | Limb hypertonia (HP:0002509) | 1.70583765 |
| 137 | Chronic hepatic failure (HP:0100626) | 1.69292414 |
| 138 | Intention tremor (HP:0002080) | 1.68829386 |
| 139 | Generalized myoclonic seizures (HP:0002123) | 1.67796869 |
| 140 | Anterior segment dysgenesis (HP:0007700) | 1.67082242 |
| 141 | Hemiplegia (HP:0002301) | 1.66639562 |
| 142 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.64276283 |
| 143 | Muscular hypotonia of the trunk (HP:0008936) | 1.63344475 |
| 144 | Akinesia (HP:0002304) | 1.62400772 |
| 145 | Septo-optic dysplasia (HP:0100842) | 1.61026992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.32105852 |
| 2 | MAP3K4 | 3.65965633 |
| 3 | NTRK3 | 3.36662278 |
| 4 | LATS2 | 3.27809286 |
| 5 | MARK1 | 3.27571489 |
| 6 | PAK6 | 3.25310817 |
| 7 | MINK1 | 3.19433577 |
| 8 | KSR2 | 2.81247449 |
| 9 | MAP2K7 | 2.48663057 |
| 10 | MAPK13 | 2.21022730 |
| 11 | LMTK2 | 2.11238853 |
| 12 | FRK | 2.07165259 |
| 13 | MAP2K4 | 1.94835183 |
| 14 | PHKG2 | 1.91465499 |
| 15 | PHKG1 | 1.91465499 |
| 16 | NTRK1 | 1.91430245 |
| 17 | PRKD3 | 1.89085459 |
| 18 | KSR1 | 1.87477701 |
| 19 | WNK4 | 1.86352270 |
| 20 | STK38 | 1.69251543 |
| 21 | MAP3K6 | 1.67281328 |
| 22 | NTRK2 | 1.50346596 |
| 23 | ARAF | 1.50077014 |
| 24 | MAP3K12 | 1.49554436 |
| 25 | INSRR | 1.48308379 |
| 26 | UHMK1 | 1.44377505 |
| 27 | BRAF | 1.36229677 |
| 28 | LIMK1 | 1.33169941 |
| 29 | TAOK1 | 1.25174271 |
| 30 | MAP4K2 | 1.24752143 |
| 31 | MAPKAPK3 | 1.23893749 |
| 32 | RET | 1.23014077 |
| 33 | MUSK | 1.21418125 |
| 34 | DYRK2 | 1.20139600 |
| 35 | STK38L | 1.19865935 |
| 36 | ERBB4 | 1.17482618 |
| 37 | GRK5 | 1.16073638 |
| 38 | CDK5 | 1.15211626 |
| 39 | SCYL2 | 1.11455453 |
| 40 | MAP3K2 | 1.04671928 |
| 41 | GRK1 | 1.04355247 |
| 42 | SGK494 | 1.03643687 |
| 43 | SGK223 | 1.03643687 |
| 44 | TYRO3 | 1.02675932 |
| 45 | PAK3 | 1.01352070 |
| 46 | EPHA4 | 1.01275642 |
| 47 | ADRBK2 | 0.98864089 |
| 48 | CDK14 | 0.94689113 |
| 49 | CAMK2B | 0.94248256 |
| 50 | WNK1 | 0.93047163 |
| 51 | CDK18 | 0.92097073 |
| 52 | CSNK1G2 | 0.91660733 |
| 53 | PINK1 | 0.90145982 |
| 54 | ZAK | 0.89150296 |
| 55 | CDK15 | 0.88835652 |
| 56 | NEK1 | 0.86349710 |
| 57 | FES | 0.85169359 |
| 58 | CAMK1G | 0.84745467 |
| 59 | CASK | 0.84722720 |
| 60 | RAF1 | 0.82888503 |
| 61 | DYRK1A | 0.81470119 |
| 62 | TRIM28 | 0.81341925 |
| 63 | CAMKK1 | 0.80176422 |
| 64 | PKN1 | 0.79410568 |
| 65 | MAPKAPK5 | 0.78481143 |
| 66 | CAMK2A | 0.78395539 |
| 67 | IRAK2 | 0.77853988 |
| 68 | CDK11A | 0.77048066 |
| 69 | TLK1 | 0.76477613 |
| 70 | MAP3K13 | 0.71982420 |
| 71 | CAMK4 | 0.71324055 |
| 72 | FGFR2 | 0.71155529 |
| 73 | DAPK1 | 0.70071597 |
| 74 | PRKCG | 0.69706339 |
| 75 | FER | 0.67668125 |
| 76 | PRKAA1 | 0.65841721 |
| 77 | PNCK | 0.65140743 |
| 78 | MAP2K1 | 0.64947544 |
| 79 | STK39 | 0.63573202 |
| 80 | MARK2 | 0.63228408 |
| 81 | BRSK1 | 0.63145181 |
| 82 | MAPK10 | 0.60066794 |
| 83 | WNK3 | 0.59814129 |
| 84 | CSNK1G3 | 0.59349126 |
| 85 | ERBB3 | 0.58644731 |
| 86 | PLK2 | 0.58502046 |
| 87 | CAMKK2 | 0.57698939 |
| 88 | SGK2 | 0.56730890 |
| 89 | CDK8 | 0.56626566 |
| 90 | PIK3CA | 0.55848901 |
| 91 | SGK1 | 0.55443940 |
| 92 | CAMK1D | 0.55401816 |
| 93 | TAOK3 | 0.54144686 |
| 94 | PRKACA | 0.52646184 |
| 95 | CHEK2 | 0.52138677 |
| 96 | EPHA3 | 0.51411754 |
| 97 | CDK19 | 0.50472510 |
| 98 | CSNK1D | 0.50389676 |
| 99 | BCR | 0.50022886 |
| 100 | MAP2K6 | 0.48674856 |
| 101 | PRKCZ | 0.48015465 |
| 102 | NEK2 | 0.47897286 |
| 103 | TNIK | 0.47715955 |
| 104 | PRKCH | 0.47023284 |
| 105 | ROCK1 | 0.44213312 |
| 106 | CDC42BPA | 0.42122708 |
| 107 | CSNK1E | 0.41930435 |
| 108 | STK11 | 0.41574570 |
| 109 | ALK | 0.41058598 |
| 110 | CAMK2G | 0.40498199 |
| 111 | OXSR1 | 0.39919085 |
| 112 | CSNK1A1 | 0.39273439 |
| 113 | RPS6KA3 | 0.38902788 |
| 114 | ROCK2 | 0.38755108 |
| 115 | ACVR1B | 0.38362216 |
| 116 | SIK2 | 0.36969055 |
| 117 | CAMK2D | 0.36101616 |
| 118 | PRKCA | 0.35387204 |
| 119 | PRKG1 | 0.35248470 |
| 120 | CSNK1G1 | 0.34971056 |
| 121 | RPS6KA2 | 0.34671699 |
| 122 | PRKCE | 0.33813196 |
| 123 | CAMK1 | 0.33511039 |
| 124 | ERBB2 | 0.33368831 |
| 125 | MAP3K1 | 0.33297123 |
| 126 | BMPR1B | 0.33152206 |
| 127 | AURKA | 0.32170732 |
| 128 | DAPK2 | 0.31958134 |
| 129 | PRKACB | 0.31448795 |
| 130 | CSNK1A1L | 0.31355188 |
| 131 | GSK3B | 0.30655446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.85302389 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.27190744 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.51354506 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39227673 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.34086032 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.34073367 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21034052 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.18993801 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.17620847 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.16296452 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.06752480 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.97440551 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94221946 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.91111828 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.83946695 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75276174 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74428420 |
| 18 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.66461281 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62695097 |
| 20 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.55856772 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.51192462 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49945357 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44637445 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44392803 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.43457437 |
| 26 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.41634304 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.37668995 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.36541495 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35633511 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33721632 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.32902060 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30909938 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.28968088 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28672735 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.23366057 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20694472 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19086631 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18032184 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.18009695 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15836839 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.15709459 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14186278 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12581920 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.11106030 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11096600 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10449712 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10095382 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09295708 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08870532 |
| 50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05720018 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02008493 |
| 52 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.98316832 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.96954360 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95801717 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94966361 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94530169 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93452307 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92625206 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91484963 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90906951 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90471127 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90012838 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.89981067 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87315098 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86188918 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85473759 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84876545 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84324836 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83882952 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83571848 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83080001 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82462378 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80755704 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80562305 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78995260 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77997872 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.77592317 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76320231 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73389144 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73384031 |
| 81 | Basal transcription factors_Homo sapiens_hsa03022 | 0.72987197 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.70880754 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70245834 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68416555 |
| 85 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66108899 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65423450 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63832554 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63565476 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62077405 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61215348 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60723062 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60550383 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58978682 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58636363 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57917308 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57007975 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56159380 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.55970867 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55966373 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.55627275 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54868055 |
| 102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54820570 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54363506 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52733529 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52438663 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51860426 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50496777 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49971788 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49644823 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49551670 |
| 111 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49375834 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49308476 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.48565322 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48520261 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46785277 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46512205 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45594418 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45065139 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44425929 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42741647 |
| 121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41893834 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41721526 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41630209 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.40097912 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39770022 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39501481 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38642214 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37326658 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36513972 |
| 130 | Protein export_Homo sapiens_hsa03060 | 0.35394557 |
| 131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32814840 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32116814 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30492947 |
| 134 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29899110 |
| 135 | RNA polymerase_Homo sapiens_hsa03020 | 0.29859352 |

